Intellia Therapeutics's market cap is currently ―. The company's EPS TTM is $-5.417; its P/E ratio is -4.23; Intellia Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-1.38. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 11.99M	$ 13.59M	$ 12.61M	$ 13.57M	$ 13.27M
Gross Profit	$ 11.99M	$ 13.59M	$ 12.61M	$ 13.57M	-
EBIT	$ -122.08M	$ -125.16M	$ -100.14M	$ -115.33M	$ -105.53M
EBITDA	-	$ -130.09M	$ -102.66M	-	$ -103.58M
Net Income Common Stockholders	$ -122.08M	$ -123.68M	$ -100.14M	$ -109.97M	$ -113.23M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 854.79M	$ 908.07M	$ 933.54M	$ 1.19B	$ 828.19M
Total Assets	$ 1.24B	$ 1.32B	$ 1.42B	$ 1.49B	$ 1.08B
Total Debt	$ 118.34M	$ 122.33M	$ 126.13M	$ 130.70M	$ 97.65M
Net Debt	$ -736.45M	$ -785.74M	$ -807.41M	$ -1.06B	$ -730.55M
Total Liabilities	$ 205.94M	$ 218.35M	$ 227.05M	$ 1.52B	$ 259.51M
Stockholders Equity	$ 1.04B	$ 1.10B	$ 1.19B	$ 1.24B	$ 824.95M
Cash Flow	-
Free Cash Flow	-	$ -94.72M	$ -113.16M	$ -99.21M	$ -82.76M
Operating Cash Flow	$ -101.38M	$ -90.42M	$ -109.33M	$ -95.30M	$ -78.53M
Investing Cash Flow	$ 79.50M	$ -34.44M	$ -122.25M	$ -24.73M	$ 47.64M
Financing Cash Flow	$ 19.10M	$ 1.05M	$ 2.22M	$ 2.11M	$ 23.98M

Currency in USD

Intellia Therapeutics Earnings and Revenue History

Income Statement >

Intellia Therapeutics Debt to Assets

Balance Sheet >

Intellia Therapeutics Cash Flow

Cash Flow >

Intellia Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing